|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Jan―31 |
Thrombocytopenia in COVID-19 patients: The role of fondaparinux and succinates in improving outcomes (exchange of experience) |
N. Yu. Semigolovskii, V. A. Ratnikov, I. S. Simutis, A. V. Svetlikov, L. G. Ermolaeva, D. S. Salygina, et al. (+4) M. S. Danilov, S. N. Semigolovskii, A. A. Gorokhov, M. S. Mazurenko |
2 |
[GO] |
2024―Dec―12 |
Prediction of restrictive ventilation disorders after COVID-19 |
O. I. Savushkina, E. S. Muravyeva, S. N. Avdeev, A. A. Zaitsev, G. N. Nekludova, E. V. Kryukov |
3 |
[GO] |
2024―Dec―12 |
The role of pulmonary surfactant in the pathogenesis of bronchopulmonary diseases and the prospects of surfactant therapy in COVID-19 |
I. V. Bliznova, L. N. Tolmacheva, M. S. Danilova, R. A. Bontsevich |
4 |
[GO] |
2024―Nov―12 |
The use of a heated helium-oxygen mixture in patients with severe COVID-19 and ARDS against the background of standard therapy and noninvasive ventilation |
G. S. Nuralieva, A. E. Shmidt, A. I. Yaroshetskiy, G. V. Nekludova, V. V. Gaynitdinova, N. A. Tsareva, et al. (+5) Z. M. Merzhoeva, S. Yu. Chikina, N. V. Trushenko, I. S. Avdeev, S. N. Avdeev |
5 |
[GO] |
2024―Nov―08 |
Somatic and neurological comorbidities in COVID-19 with fatal outcome |
O. I. Ignatieva, A. V. Sergachev, V. F. Pavelkina, V. N. Ignatiev, A. A. Erovichenkov |
6 |
[GO] |
2024―Jun―10 |
The effect of levilimab on the clinical presentations and changes in inflammatory biomarkers in outpatients with mild to moderate COVID-19 |
T. N. Nizhenko, E. V. Shikh, Zh. M. Sizova, V. N. Drozdov, N. I. Lapidus, A. E. Pakhomova |
7 |
[GO] |
2024―Jun―10 |
6-minute walk test in patients hospitalized with COVID-19 |
T. V. Kanaeva, N. A. Karoli |
8 |
[GO] |
2024―Jun―10 |
Incidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps |
E. V. Lyubimova, E. L. Savlevich, A. V. Zurochka, E. S. Mitrofanova, O. M. Kurbacheva |
9 |
[GO] |
2024―Jun―10 |
Fatigue syndrome after COVID-19 infection: results of personal observations |
P. E. Kolesnikov, A. A. Vizel, A. R. Abashev, L. V. Davydova |
10 |
[GO] |
2024―May―22 |
Platelet link of hemostasis in polymorbid patients with acute coronary syndrome and COVID-19 |
L. I. Kadnikov, N. V. Izmozherova, A. A. Popov, I. P. Antropova |
11 |
[GO] |
2024―May―22 |
Information systems as a source of meaningful information in an epidemic: experience and lessons in restoring routine otorhinolaryngology care after the COVID-19 pandemic |
A. A. Korneenkov, P. A. Ovchinnikov, E. A. Vyazemskaya, A. Y. Medvedeva, Yu. K. Yanov |
12 |
[GO] |
2024―May―14 |
A case of granulomatos is with polyangiitis (Wegener’s) after a patient’s suffering from a new coronavirus infection COVID-19 |
M. A. Balaganskaya, S. N. Galkina, A. V. Teteneva, E. A. Starovoytova, N. A. Kirillova, T. V. Sorokina, et al. (+4) N. Yu. Kolesnik, K. S. Sergeeva, T. A. Zagromova, S. V. Fedosenko |
13 |
[GO] |
2024―May―14 |
Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients |
N. I. Voloshin, V. V. Salukhov, A. A. Minakov, M. O. Prokhorova, T. A. Belyakova, V. V. Kochukova |
14 |
[GO] |
2024―Apr―23 |
Surfactant protein D as a marker of persistent impairment of the lungs diffusion capacity in the long-term period in patients who had suffered from severe COVID-19 |
G. B. Abdullaeva, M. V. Kozhevnikova, D. S. Valiulina, Yu. N. Belenkov |
15 |
[GO] |
2024―Jan―22 |
The course of subacute thyroiditis from COVID-19 infection |
M. I. Strokova, T. B. Morgunova, V. V. Fadeev |
16 |
[GO] |
2024―Jan―22 |
Obstetric and perinatal outcomes after a new coronavirus infection in the first and second trimesters of pregnancy |
N. F. Khvorostukhina, D. I. Sheveleva, D. A. Novichkov, N. N. Stepanova, G. S. Suvorova, O. S. Odnokozova, Yu. K. Akhmedova |
17 |
[GO] |
2023―Dec―06 |
A clinical case of viral myocarditis associated with sars-cov-2 in a health worker |
S. A. Babanov, T. A. Azovskova, N. E. Lavrentyeva, R. A. Baraeva |
18 |
[GO] |
2023―Nov―21 |
Hypoxemia without dyspnea in COVID-19 |
D. V. Fan, G. V. Nekludova, Z. G.-M. Berikkhanov, S. N. Avdeev |
19 |
[GO] |
2023―Nov―21 |
Characteristics of patients with sarcoidosis who referred to a pulmonologist during the COVID-19 pandemic |
A. A. Vizel, I. Yu. Vizel, G. R. Shakirova, L. A. Vizel |
20 |
[GO] |
2023―Nov―21 |
Geography of patients in the federal ENT hospital before and after the COVID-19 pandemic: changing spatial patterns and characteristics |
A. A. Korneenkov, P. A. Ovchinnikov, E. E. Vyazemskaya, A. Yu. Medvedeva, Yu. K. Yanov |
21 |
[GO] |
2023―Nov―21 |
Difficulties in diagnosing complications of COVID-19: description of a clinical case |
E. V. Loshkova, M. V. Rebrienko, I. V. Doroshenko, T. S. Lyulka, A. V. Budkin, Yu. S. Rafikova, et al. (+5) E. I. Kondratyeva, A. I. Khavkin, N. D. Odinaeva, A. L. Solnyshko, Е. V. Golikova |
22 |
[GO] |
2023―Nov―07 |
Characteristics of post COVID-19 condition in children after mild COVID-19 |
A. S. Chernyavskaya, O. I. Simonova, N. Yu. Kashirskaya |
23 |
[GO] |
2023―Nov―07 |
Influence of liver attenuation on the severity of course COVID-19: a retrospective cohort study |
Yu. F. Shumskaya, A. P. Gonchar, M. G. Mnatsakanyan, I. A. Blokhin, R. V. Reshetnikov, Yu. A. Vasilev |
24 |
[GO] |
2023―Oct―23 |
Cardiovascular complications in the context of COVID-19: arrhythmias |
A. S. Zmitrukevich, A. E. Mamedova, E. V. Reznik |
25 |
[GO] |
2023―Aug―22 |
Epidemiological analysis of systemic mycoses in COVID-19 |
A. V. Martynova, O. S. Pavlova, E. P. Yusupova |
26 |
[GO] |
2023―Aug―22 |
New coronavirus infection as a risk-factor for the development of tuberculosis: a clinical observation |
O. E. Russkikh, P. G. Sysoev, D. A. Kudlay |
27 |
[GO] |
2023―Aug―01 |
The impact of novel coronavirus infection and Sputnik V / Sputnik Light vaccination on menstrual function |
M. Yu. Fokina, A. E. Malikova, K. R. Bakhtiyarov |
28 |
[GO] |
2023―Jul―24 |
General infectious and neurological manifestations of new coronavirus infection COVID-19 |
O. I. Ignatieva, V. F. Pavelkina, V. N. Ignatiev, A. A. Erovichenkov |
29 |
[GO] |
2023―May―29 |
Hyperferritinemia, chronic hepatitis C and COVID-19: what do they have in common? |
M. I. Gonik, E. L. Bueverova, A. O. Bueverov |
30 |
[GO] |
2023―May―12 |
Assessment of working conditions and risks caused by the COVID-19 pandemic: results of an online survey of personnel of medical organizations |
A. A. Korneenkov, P. A. Ovchinnikov, E. E. Vyazemskaya, V. V. Dvoryanchikov, S. V. Ryazantsev, Yu. K. Yanov, I. V. Fanta |
31 |
[GO] |
2023―May―12 |
The effectiveness of a polyvalent antigenic complex including bacterial lysates in the treatment and prevention of rhinosinusitis against the background of acute respiratory viral infections and COVID-19 (clinical description) |
A. A. Krivopalov, S. V. Ryazantsev, Yu. S. Aleksanian, A. I. Glyshchenko |
32 |
[GO] |
2023―May―12 |
Glucocorticoids in the combination therapy of COVID-19 |
V. V. Skvortsov, A. V. Tumarenko, E. A. Malyakina, G. I. Maljakin |
33 |
[GO] |
2023―May―12 |
Comparative study of myocardial damage in hantavirus and new coronavirus infection |
G. A. Galieva, G. Kh. Mirsaeva, R. M. Fazlyeva, E. R. Kamaeva, O. L. Andrianova, D. I. Masalimova, et al. (+3) A. Kh. Islamgulov, V. V. Nikulina, A. R. Imaeva |
34 |
[GO] |
2023―May―12 |
Possibilities of personalized pharmacotherapy and medical rehabilitation of patients with long COVID from the perspective of clinical metabolomics |
I. V. Kukes, V. G. Lim, K. A. Ivantsov, E. Yu. Solovyeva, L. P. Sokolova, I. R. Gilmutdinova, et al. (+2) P. B. Glagovskiy, M. S. Ptitsyn |
35 |
[GO] |
2023―Apr―19 |
The use of inhaled tauractant therapy in the subacute period of COVID-19 |
O. O. Voronkova, A. A. Starzhevskaia, V. G. Skachek, E. F. Rogova, G. B. Abdullaeva, O. E. Buyanova, et al. (+2) M. V. Kozhevnikova, Yu. N. Belenkov |
36 |
[GO] |
2023―Apr―19 |
Antibacterial therapy: questions posed by COVID-19 and real clinical practice |
A. A. Vizel, I. Yu. Vizel |
37 |
[GO] |
2023―Apr―19 |
Early distinctive clinical and hematological signs of hemorrhagic fever with renal syndrome and a new coronavirus infection occurring with lung damage |
G. A. Galieva, G. Kh. Mirsaeva, G. A. Mavzyutova, N. N. Mironchuk, L. Kh. Amineva, E. R. Kamaeva, et al. (+2) T. N. Lisovskaya, A. R. Mukhetdinov |
38 |
[GO] |
2023―Apr―19 |
Experience of using systemic glucocorticoids during reconvalescence of patients after a new coronavirus infection of moderate severity |
Yu. V. Rudakov, A. A. Bogomolov, V. V. Salukhov, M. A. Kharitonov, A. A. Chugunov |
39 |
[GO] |
2023―Apr―18 |
Headaches associated with COVID-19 |
G. R. Tabeeva |
40 |
[GO] |
2023―Mar―17 |
The association of hair loss and coronavirus infection COVID-19 - facts and hypotheses |
I. O. Smirnova, O. M. Medetskaya, Ya. G. Petunova, P. D. Ptashnikova, N. V. Shin, A. O. Zhelonkina, et al. (+2) A. R. Zhelonkin, O. N. Smirnova |
41 |
[GO] |
2023―Mar―14 |
Features of the treatment of children with mild asthma in the context of the COVID-19 pandemic |
T. N. Surovenko, E. F. Zhukalina, Iu. N. Krasnova |
42 |
[GO] |
2023―Mar―14 |
Quality of life in children after a new coronavirus infection |
E. P. Isaeva, O. V. Zaytseva, E. E. Lokshina, O. A. Murtazaeva, S. V. Zaytseva, N. A. Sirota, et al. (+2) D. A. Ponkratov, I. V. Zyabkin |
43 |
[GO] |
2023―Jan―23 |
Analysis of severity and evaluation of prognosis in elderly patients with bronchial asthma and severe COVID-19 |
V. V. Gaynitdinova, S. N. Avdeev, A. A. Pozdniakova, A. E. Vlasenko, T. Yu. Gneusheva, K. A. Ter-Akopian, D. U. Allaberdina |
44 |
[GO] |
2023―Jan―23 |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
O. O. Yanushevich, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, M. M. Sharipova, M. V. Yakovleva, et al. (+5) I. I. Shantyr, M. A. Vlasenko, K. G. Gurevich, O. V. Levchenko, I. V. Maev |
45 |
[GO] |
2023―Jan―23 |
Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 |
I. I. Temirbulatov, A. V. Kryukov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, A. A. Kachanova, et al. (+6) Zh. A. Sozaeva, A. S. Zhiryakova, Yu. V. Shevchuk, V. I. Vechorko, O. V. Averkov, D. A. Sychev |
46 |
[GO] |
2023―Jan―23 |
Patterns and features of the course of the early and late stages recovery period after ischemic stroke associated with COVID-19 |
E. N. Kabaeva, A. V. Ershov, P. F. Litvitskiy, D. T. Rejepov, A. A. Pozdnyakov |
47 |
[GO] |
2023―Jan―23 |
Features of the pathology of the lymphoid ring of the pharynx in children during the COVID-19 pandemic |
A. V. Andrianov, M. V. Drozdova, Yu. S. Preobrazhenskaya |
48 |
[GO] |
2023―Jan―23 |
Hospital readmissions of patients with COVID-19: causes, features, outcomes |
O. N. Potanina, S. A. Ayrapetyan, S. O. Mazurenko, V. V. Strizheletsky, L. S. Palchikova, N. A. Teplyakova, et al. (+3) L. G. Ermolaeva, Iu. M. Gomon, N. Yu. Semigolovskii |
49 |
[GO] |
2023―Jan―23 |
A rational approach to drug therapy of acute bacterial sinusitis in patients who have had a coronavirus infection |
M. Yu. Korkmazov, N. V. Kornova, O. A. Gizinger, K. S. Zyryanova, A. S. Beloshangin |
50 |
[GO] |
2022―Nov―22 |
Local treatment of acute rhinosinusitis in the era of COVID-19 |
A. A. Krivopalov, S. V. Ryazantsev, V. V. Turieva |
51 |
[GO] |
2022―Nov―22 |
Orofacial and facial pain during the new coronavirus infection (COVID-19) pandemic. Choosing a non-steroid anti-inflammator - focus on nimesulide |
D. I. Trukhan, A. F. Sulimov, I. N. Stepanov, L. Yu. Trukhan, E. N. Degovtsov |
52 |
[GO] |
2022―Nov―16 |
Efficacy of dornase alfa as part of background therapy in children with cystic fibrosis during the COVID-19 pandemic |
O. I. Simonova, Yu. V. Gorinova, A. S. Chernyavskaya |
53 |
[GO] |
2022―Nov―10 |
Topical antibiotic therapy for perforated otitis in the COVID-19 pandemic |
S. V. Ryazantsev, K. A. Balatskaya, I. V. Tkachuk, A. E. Golovanov, P. V. Kireev |
54 |
[GO] |
2022―Oct―18 |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
M. M. Sharipova, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich |
55 |
[GO] |
2022―Oct―18 |
Correct treatment regimen and inhalation technique are the components of success in bronchial asthma in the era of COVID-19 |
Yu. G. Belotserkovskaya, A. G. Romanovskikh, I. P. Smirnov |
56 |
[GO] |
2022―Oct―18 |
Functional and quantitative computed tomographic changes in the bronchopulmonary system in patients who have undergone COVID-19 |
A. V. Cherniak, N. A. Karchevskaya, I. M. Skorobogach, O. V. Leshchinskaya, E. N. Kalmanova, K. A. Zykov, S. S. Petrikov |
57 |
[GO] |
2022―Oct―18 |
Features of laboratory parameters in the new coronavirus infection COVID-19 against the background of diabetes mellitus and chronic heart failure |
E. Yu. Plotnikova, M. A. Sinkov, L. K. Isakov, M. N. Sinkova, A. Yu. Tarasova, V. N. Zolotukhina |
58 |
[GO] |
2022―Oct―18 |
COVID-19 and lung damage in obese patients: results of a prospective study |
A. V. Buchneva, N. V. Chichkova, E. V. Fominykh, N. V. Krupochkina, V. V. Fomin |
59 |
[GO] |
2022―Oct―18 |
New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions |
D. I. Trukhan |
60 |
[GO] |
2022―Oct―07 |
Evaluation of the efficacy and safety of remdesivir in hospitalized patients with a new coronavirus infection COVID-19: data from a Russian university clinic |
O. O. Yanushevich, I. V. Maev, N. I. Krikheli, O. V. Levchenko, D. N. Andreev, P. S. Sokolov, et al. (+5) A. K. Fomenko, M. K. Devkota, N. G. Andreev, A. V. Zaborovsky, D. I. Shefer |
61 |
[GO] |
2022―Oct―07 |
Nutrition of elderly persons during a new coronavirus infection |
S. A. Solgalova, S. G. Kechedzhieva |
62 |
[GO] |
2022―Aug―15 |
Рrognostic value of proadrenomedullin in patients with COVID-19 |
A. A. Astapovskii, V. N. Drozdov, E. V. Shikh, N. B. Lazareva, S. Yu. Serebrova |
63 |
[GO] |
2022―Aug―15 |
Therapy experience in alopecia after COVID-19 |
O. A. Katkhanova, M. V. Golubchenko |
64 |
[GO] |
2022―Aug―15 |
The effect of a new coronavirus infection caused by the SARS-CoV-2 virus on microcirculation in the conjunctiva |
T. N. Safonova, G. V. Zaitseva, N. P. Kintyukhina |
65 |
[GO] |
2022―Aug―10 |
Coronavirus infection and psoriasis: relationship and consequences |
K. V. Katkova, E. V. Denisova, A. G. Soboleva, E. A. Pechatnikova, O. V. Zhukova, V. V. Sobolev, I. M. Korsunskaya |
66 |
[GO] |
2022―Jul―14 |
New devices to control fever in children with COVID-19 and other acute respiratory infections |
I. N. Zakharova, I. M. Osmanov, I. V. Berezhnaya, N. G. Sugian, I. D. Maykova, E. R. Samitova, et al. (+3) D. S. Kolushkin, V. V. Pupykina, I. E. Rodionov |
67 |
[GO] |
2022―Jul―07 |
Interleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19 |
N. V. Muravyeva, B. S. Belov |
68 |
[GO] |
2022―Jul―07 |
Colchicine for the treatment of COVID-19: short path from theory to practice |
M. S. Eliseev, O. V. Zheliabina |
69 |
[GO] |
2022―May―17 |
Evaluation of the efficacy and safety of the 7% hypertonic solution with hyaluronic acid in patients with COVID-19 in the outpatient phase |
G. S. Anikin, I. V. Stozhkova, S. S. Sharonova, E. V. Kurdyukova |
70 |
[GO] |
2022―May―17 |
The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection |
T. Yu. Vladimirova, A. M. Popova, M. N. Popov |
71 |
[GO] |
2022―May―17 |
Features of the treatment of acute otitis media in the COVID-19 pandemic |
S. V. Ryazantsev, I. V. Tkachuk, А. E. Golovanov, P. V. Kireev, K. A. Balatskaya, O. S. Donskaya |
72 |
[GO] |
2022―Apr―28 |
Features of the course of COVID-19 in patients with comorbid pathology |
M. M. Sharipova, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich, I. V. Maev |
73 |
[GO] |
2022―Apr―28 |
Prospects for finding means of non-specific prevention of COVID-19 infection |
D. V. Usenko |
74 |
[GO] |
2022―Apr―28 |
New opportunities in the treatment of asthenic symptoms after a new coronavirus infection |
V. N. Shishkova, A. I. Martynov |
75 |
[GO] |
2022―Apr―08 |
Astenic syndrome in you students with different online-behaviors during the pandemic of new coronavirus infection COVID-19 |
L. S. Evert, N. Yu. Grishkevich, Yu. R. Kostyuchenko, S. S. Seren-ool, S. A. Bakhshieva |
76 |
[GO] |
2022―Apr―08 |
Factors affecting the content of Ig G-antibodies to S-protein SARS-CoV-2 in the blood of reconvalescents after new coronaviral infection (COVID-19) |
E. V. Kryukov, V. V. Salukhov, B. N. Kotiv, D. V. Ovchinnikov, Yu. V. Andreychuk, D. G. Denisov, et al. (+5) A. B. Bogomolov, M. A. Kharitonov, Yu. V. Rudakov, P. S. Sadovnikov, A. A. Chugunov |
77 |
[GO] |
2022―Apr―08 |
Possibilities of information systems for prediction of outcomes of new coronavirus infection COVID-19 |
I. V. Demko, E. E. Korchagin, O. A. Cherkashin, N. V. Gordeeva, D. A. Anikin, D. A. Anikina |
78 |
[GO] |
2022―Apr―08 |
Surfactant therapy for pneumonia COVID-19 of obstetric patients |
M. V. Shvechkova, I. I. Kukarskaya, A. E. Bautin, T. V. Legalova, R. N. Marchenko, A. S. Shvechkova, et al. (+2) E. Yu. Kukarskaya, E. A. Yakovleva |
79 |
[GO] |
2022―Apr―08 |
Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia |
M. V. Ezhov, T. E. Kolmakova, M. M. Matveeva, I. A. Alekseeva |
80 |
[GO] |
2022―Mar―14 |
Psychiatric and neurological aspects of sleep disturbance after coronavirus infection (COVID-19) |
E. D. Spektor, M. G. Poluektov |
81 |
[GO] |
2022―Mar―14 |
Cognitive impairment in hospitalized patients with COVID-19 |
S. P. Bordovsky, K. D. Tolmachev, K. K. Kriukova, O. I. Gurina, I. S. Preobrazhenskaya |
82 |
[GO] |
2022―Mar―07 |
COVID-19 pandemic and kidney disease in children: literature review and own regional observations |
O. V. Borisova, G. A. Makovetskaya, L. I. Mazur, N. M. Bochkareva, V. N. Barinov, O. N. Yashkina, et al. (+2) S. A. Kolesnikov, S. N. Reshetova |
83 |
[GO] |
2022―Jan―11 |
Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR) |
I. N. Tikhonov, V. T. Ivashkin, M. S. Zharkova, M. V. Maevskaya, S. N. Koloteeva, A. S. Sarsenbaeva, et al. (+4) L I. Tkachenko, O. V. Aronova, E. K. Tsvetaeva, N I. Trofimovskaya |
84 |
[GO] |
2022―Jan―11 |
Probiotics: relevant during the coronavirus (COVID-19) infection pandemic? |
M. A. Shevyakov |
85 |
[GO] |
2021―Dec―01 |
Possibilities of correction of post viral other dysfunction in the application of COVID-19 |
T. Yu. Vladimirova, L. A. Baryshevskaya, A. V. Kurenkov |
86 |
[GO] |
2021―Dec―01 |
Clinical case of COVID-19 in a patient treated with alemtuzumab |
E. V. Popova |
87 |
[GO] |
2021―Dec―01 |
Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
V. A. Golovacheva, A. A. Golovacheva |
88 |
[GO] |
2021―Dec―01 |
Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
N. V. Orlova, V. V. Lomaychikov |
89 |
[GO] |
2021―Nov―02 |
Immunoprophylaxis of influenza, acute and recurrent respiratory infections during the COVID-19 pandemic |
A. A. Girina, A. L. Zaplatnikov, E. I. Burtseva, V. I. Svintsitskaya, I. D. Maykova, N. F. Dubovets, et al. (+6) N. V. Koroid, I. V. Lepiseva, A. Е. Voskanyan, D. N. Tkacheva, A. D. Panova, S. A. Motorny |
90 |
[GO] |
2021―Nov―01 |
Influenza in the COVID-19 era: principles of modern pharmacotherapy |
N. B. Lazareva |
91 |
[GO] |
2021―Nov―01 |
Analysis of the antibiotic consumption on the backdrop of the COVID-19 pandemic: hospital level |
K. I. Karnoukh, N. B. Lazareva |
92 |
[GO] |
2021―Nov―01 |
Clinical case of nebulized surfactant therapy for severe COVID-19-associated pneumonia at the 2nd stage of rehabilitation treatment |
I. Yu. Stulikova, A. V. Tsvetkova, E. S. Koneva, T. V. Shapovalenko |
93 |
[GO] |
2021―Nov―01 |
Optimization of therapy of patients with bronchial asthma in conditions of coronavirus infection |
E. M. Kostina, E. Yu. Trushina, E. A. Orlova |
94 |
[GO] |
2021―Nov―01 |
The effectiveness of combination of 7% hypertonic saline and 0.1% natrii hyaluronas in patients with chronic obstructive pulmonary disease who have suffered a new coronavirus infection |
O. N. Titova, N. A. Kuzubova, D. B. Skliarova, A. L. Aleksandrov, N. V. Egorova |
95 |
[GO] |
2021―Nov―01 |
Coronavirus pneumonia in kidney transplant recipients: current evidence from own clinical experience |
I. V. Lekareva, A. L. Emelianova, E. V. Kalinina, A. R. Babaeva, E. V. Scherbinina |
96 |
[GO] |
2021―Oct―20 |
Liver drug damage: possibilities of polyionic succinate-methioninic complex during the pandemic of new coronavirus infection (COVID-19) |
D. I. Trukhan, E. L. Davydov |
97 |
[GO] |
2021―Oct―18 |
The recovery of endothelial function in novel coronavirus infection COVID-19 (review) |
E. V. Roitman |
98 |
[GO] |
2021―Oct―17 |
The use of combined hormonal contraception in the context of the COVID-19 pandemic |
A. T. Uruymagova, V. N. Prilepskaya, E. A. Mezhevitinova, M. T. Poghosyan |
99 |
[GO] |
2021―Oct―17 |
Recurrent vulvovaginal candidiasis during COVID-19 pandemic: medical algorithm |
N. M. Nazarova, K. I. Gusakov, S. V. Pavlovich, E. R. Dovletkhanova |
100 |
[GO] |
2021―Sep―20 |
Possibilities of daytime anxolytics in the correction of residual neurological manifestations of COVID-19 |
E. A. Alexandrova, E. V. Parshina, I. V. Borodacheva, A. G. Suslov, K. M. Beliakov, V. S. Yulin, S. V. Fomin |
101 |
[GO] |
2021―Sep―20 |
Pathogenetic bases of the use of antifibrotic therapy with Bovhyaluronidazum azoximerum in patients with new coronavirus infection COVID-19 |
O. A. Chernyavskaya, A. V. Osipov |
102 |
[GO] |
2021―Sep―20 |
The role and place of glucocorticosteroids in treatment of COVID-19 pneumonia without hypoxemia |
V. V. Salukhov, E. V. Kryukov, A. A. Chugunov, M. A. Kharitonov, Yu. V. Rudakov, R. E. Lakhin, et al. (+6) V. V. Dancev, I. A. Stepanenko, M. O. Gurba, T. V. Stepanova, A. V. Bolekhan, L. H. Arzhavkina |
103 |
[GO] |
2021―Sep―20 |
Safety and efficacy of acetylsalicylic acid in the secondary prevention of cardiovascular diseases in combination with comorbid diseases. COVID-19 treatment options |
O. A. Tsvetkova, O. O. Voronkova |
104 |
[GO] |
2021―Sep―20 |
Influence of coronavirus infection on the course of psoriasis |
K. V. Katkova, K. T. Plieva, E. V. Denisova, O. V. Zhukova, A. V. Volnukhin, I. M. Korsunskaya |
105 |
[GO] |
2021―Sep―20 |
Differential diagnosis of myocardial infarction and myopericarditis during a pandemic |
E. V. Konstantinova, M. R. Atabegashvili, A. A. Savicheva, A. P. Nesterov, M. Yu. Gilyarov |
106 |
[GO] |
2021―Aug―12 |
Clinical observation of the course of COVID-19 in patients with multiple sclerosis during ocrelizumab therapy: two clinical cases |
E. V. Popova, M. I. Alexandrov, I. A. Trubnikova, S. R. Zeynalova |
107 |
[GO] |
2021―Aug―12 |
Preventive vaccination compliance among medical students and pediatricians during the COVID-19 pandemic |
A. V. Dmitriev, N. V. Fedinа, T. G. Tkachenko, R. A. Gudkov, V. I. Petrova, А. L. Zaplatnikov |
108 |
[GO] |
2021―Aug―12 |
Antirheumatic drugs and COVID-19: frustrations and hopes |
E. S. Aronova, B. S. Belov |
109 |
[GO] |
2021―Aug―12 |
Modern approaches to the diagnosis and treatment of anxiety disorders associated with a new coronavirus infection |
P. V. Aronov, G. N. Belskaya, I. A. Nikiforov |
110 |
[GO] |
2021―Aug―12 |
Motor-speech disorders in a patient with a vertebrobasilar stroke affected by coronavirus infection (clinical observation) |
A. V. Obukhova, N. N. Koberskaya, D. A. Artemev |
111 |
[GO] |
2021―Aug―08 |
Limitations and opportunities of cancer treatment in the COVID-19 pandemic |
R. V. Orlova, E. A. Kaledina, A. M. Malkova, N. V. Zhukova, P. A. Naymushina, N. P. Beliak, et al. (+6) A. E. Jukova, A. S. Sarmatova, N. A. Karaseva, I. V. Egorova, K. N. Teslenko, A. V. Tarasov |
112 |
[GO] |
2021―Jun―08 |
Hair loss due to a new coronavirus infection: treatment approaches |
L. R. Sakania, O. O. Melnichenko, I. M. Korsunskaya |
113 |
[GO] |
2021―May―13 |
Case of severe liver damage in COVID-19 |
E. Yu. Plotnikova, E. N. Baranova, M. S. Karyagina, O. A. Vorosova, K. A. Krasnov |
114 |
[GO] |
2021―May―13 |
Preventive and therapeutic role of nasal irrigation in management of acute respiratory disease during COVID-19 pandemic and beyond |
V. M. Svistushkin, Zh. T. Mokoyan |
115 |
[GO] |
2021―May―13 |
Obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons |
S. V. Tikhonov, V. D. Dekkanova, S. A. Vinnichuk, T. S. Fil, N. V. Bakulina |
116 |
[GO] |
2021―Apr―21 |
Innovative methods of rehabilitation at the outpatient and homestages in patients after pneumonia COVID-19 |
T. L. Alenskaya |
117 |
[GO] |
2021―Apr―21 |
Nutritional problems of patients infected with COVID-19 and potential for nutritional management of disorders |
T. L. Pilat, S. N. Alekseenko, V. A. Krutova, M. Yu. Akimov, I. V. Radysh, T. N. Umnova, et al. (+4) A. V. Istomin, E. A. Gordeeva, M. M. Korosteleva, R. A. Khanferyan |
118 |
[GO] |
2021―Apr―21 |
Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system |
S. G. Kanorskiy |
119 |
[GO] |
2021―Apr―21 |
Cognitive impairment in COVID-19 survivors |
N. V. Pizova, N. A. Pizov, A. V. Pizov |
120 |
[GO] |
2021―Apr―21 |
The effect of renin-angiotensin-aldosterone blockers on SARS-CoV-2 infection in adults: a systematic review of studies and meta-analyzes |
М. V. Leonova |
121 |
[GO] |
2021―Mar―22 |
Modern opportunities of interferons in treatment of children with COVID-19 |
Asiya I. Safina, Olga V. Sharipova, Ildus Ya. Lutfullin, Olga S. Naumova, Maria A. Daminova |
122 |
[GO] |
2021―Mar―22 |
Community-acquired pneumonia in children in the era of the COVID-19 pandemic. What has changed? |
Olga V. Zaytseva, Svetlana V. Zaytseva, Evelina E. Lokshina, Dmitriy V. Khaspekov, Nadezhda V. Tkachenko, Natalya A. Sholokhova, et al. (+5) Elena V. Kulikova, Khilda Yu. Simonovskaya, Anna Yu. Tomilova, Adam T. Barkinkhoev, Tatyana Yu. Belyaeva |
123 |
[GO] |
2021―Jan―18 |
Topical issues of diagnostics, examination and treatment of patients with COVID-19-associated pneumonia in different countries and continents |
V. V. Salukhov, M. A. Kharitonov, E. V. Kryukov, T. V. Stepanova, A. V. Nikolaev, Yu. V. Rudakov, et al. (+2) A. B. Bogomolov, A. A. Chugunov |
124 |
[GO] |
2021―Jan―18 |
Vitamin D is a strategic blow to coronavirus infection |
V. V. Salukhov, E. A. Kovalevskaya |
125 |
[GO] |
2020―Nov―29 |
Effectiveness of pathogenetic therapy for infectious diarrhea in children with COVID-19 |
D. A. Khavkina, T. A. Ruzhentsova, R. V. Popova, P. V. Chukhlyaev, A. A. Garbuzov, N. A. Meshkova |
126 |
[GO] |
2020―Nov―29 |
Risks and control of bronchial asthma in children in conditions of COVID-19 pandemic |
Article Editorial |
127 |
[GO] |
2020―Nov―23 |
Antagonism between pneumococcal vaccines and COVID-19 |
A. M. Kostinov, M. P. Kostinov, C. V. Mashilov |
128 |
[GO] |
2020―Nov―23 |
Predicting the duration of inpatient treatment for COVID-19 patients |
V. V. Tsvetkov, I. I. Tokin, D. A. Lioznov, E. V. Venev, A. N. Kulikov |
129 |
[GO] |
2020―Nov―23 |
Inhaled surfactant in patients with covid-19 who took high-flow oxygen: the results of a retrospective analysis |
A. V. Averyanov, T. V. Klypa, O. I. Balionis, M. V. Bychinin, A. V. Cherniak, A. V. Troitskiy, E. V. Trifonova |
130 |
[GO] |
2020―Nov―23 |
Allergic rhinitis during a coronavirus pandemic: difficulties of diagnosis and features of therapy |
O. V. Sebekina, E. V. Peredkova, N. M. Nenasheva, Yu. V. Grebennikova |
131 |
[GO] |
2020―Nov―16 |
Experience in managing psoriasis patients receiving targeted therapy during the COVID-19 pandemic |
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva, M. N. Ostretsova |
132 |
[GO] |
2020―Oct―23 |
Dietary management of digestive and gastrointestinal disorders after long-term self-isolation and lockdown as well as patients with SARS-CoV-2 during the rehabilitation period |
T. L. Pilat, I. V. Radysh, V. V. Surovtsev, M. M. Korosteleva, R. A. Khanferyan |
133 |
[GO] |
2020―Oct―21 |
Effectiveness of pathogenetic therapy for infectious diarrhea in children with COVID-19 |
D. A. Khavkina, T. A. Ruzhentsova, R. V. Popova, P. V. Chukhliaev, A. A. Garbuzov, N. A. Meshkova |
134 |
[GO] |
2020―Oct―15 |
Male infertility: before and after the era of SARS-CoV-2 |
R. I. Ovchinnikov, S. I. Gamidov, A. Yu. Popova, S. Kh. Izhbaev |
135 |
[GO] |
2020―Aug―08 |
Capabilities of mobile health to treat diabetes in the conditions of the COVID-19 pandemic |
L. L. Bolotskaya |
136 |
[GO] |
2020―Jul―30 |
Practical recommendation for treatment of patients with colon cancer during covid-19 pandemic |
M. Yu. Fedyanin |
137 |
[GO] |
2020―Jul―30 |
Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic |
V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi |
138 |
[GO] |
2020―Jul―16 |
COVID-19 and Rheumatology: so far, so close |
B. S. Belov, N. M. Muravyeva, G. M. Tarasova |
139 |
[GO] |
2020―Jul―16 |
Acute cerebral circulatory disorders and coronavirus disease |
N. V. Pizova, N. A. Pizov, O. A. Skachkova, M. A. Sokolov, I. A. Izmaylov, R. B. Taramakin |